Amendment: SEC Form SCHEDULE 13G/A filed by Aclaris Therapeutics Inc.
SCHEDULE 13G/A - Aclaris Therapeutics, Inc. (0001557746) (Subject)
- Amendment: SEC Form SCHEDULE 13G/A filed by StepStone Group Inc.
SCHEDULE 13G/A - StepStone Group Inc. (0001796022) (Subject)
- Amendment: SEC Form SCHEDULE 13D/A filed by Insight Molecular Diagnostics Inc.
SCHEDULE 13D/A - Insight Molecular Diagnostics Inc. (0001642380) (Subject)
- LifeStance Health Group Set to Join S&P SmallCap 600
NEW YORK, April 27, 2026 /PRNewswire/ -- LifeStance Health Group Inc. (NASD: LFST) will replace Golden Entertainment Inc (NASD: GDEN) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, May 1. S&P 500 constituent VICI Properties Inc. (NYSE:VICI) and Blake Sartini are acquiring Golden Entertainment in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name ActionCompany NameTickerGICS SectorMay 1, 2026S&P SmallCap 600AdditionLifeStance Health GroupLFSTHealth CareMay 1, 2026S&P SmallCap 600DeletionGolden EntertainmentGDENConsum
- SEC Form 144 filed by Grayscale Avalanche Staking ETF
144 - Grayscale Avalanche Staking ETF (0002035053) (Subject)
- Global Ship Lease Announces Annual Meeting of Shareholders
ATHENS, Greece, April 27, 2026 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (the "Company") has scheduled its Annual Meeting of Shareholders for June 17, 2026, at 10:00 a.m. Eastern Time (the "Annual Meeting"). The record date for determining shareholders entitled to participate at the Annual Meeting is April 20, 2026. The business of the Annual Meeting is to (i) elect three Term III Directors to serve until the 2029 Annual Meeting of Shareholders, (ii) ratify the appointment of PricewaterhouseCoopers S.A., as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, and (iii) to approve the Company's Second Amended and Restated Art
- Amendment: SEC Form SCHEDULE 13D/A filed by BlackRock ESG Capital Allocation Term Trust
SCHEDULE 13D/A - BlackRock ESG Capital Allocation Term Trust (0001864843) (Subject)
- SEC Form DEF 14A filed by Revolution Medicines Inc.
DEF 14A - Revolution Medicines, Inc. (0001628171) (Filer)
- Core Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Core Scientific, Inc./tx (0001839341) (Filer)
- Wheels Up Experience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Other Events, Financial Statements and Exhibits
8-K - Wheels Up Experience Inc. (0001819516) (Filer)
- SEC Form DEF 14A filed by GameSquare Holdings Inc.
DEF 14A - GameSquare Holdings, Inc. (0001714562) (Filer)
- Amendment: Electro-Sensors Inc. filed SEC Form 8-K: Financial Statements and Exhibits
8-K/A - ELECTRO SENSORS INC (0000351789) (Filer)
- Velo3D Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Velo3D, Inc. (0001825079) (Filer)
- SEC Form FWP filed by Veradermics Incorporated
FWP - Veradermics, Inc (0001827635) (Subject)
- SEC Form FWP filed by Blue Moon Metals Inc.
FWP - Blue Moon Metals Inc. (0001732379) (Subject)
- Amendment: SEC Form SCHEDULE 13G/A filed by Cheer Holding Inc.
SCHEDULE 13G/A - Cheer Holding, Inc. (0001738758) (Subject)
- SEC Form 20-F filed by The Metals Royalty Company Inc.
20-F - Metals Royalty Co Inc. (0002087398) (Filer)
- SEC Form DEFA14A filed by KKR & Co. Inc.
DEFA14A - KKR & Co. Inc. (0001404912) (Filer)